Patent details

Basic Information

Publication number:

EP1235562

PCT Application Number:

PCT/CA/2000/000593

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009309097

PCT Publication Number:

WO/2001/041744

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CHRONOTHERAPEUTIC DILTIAZEM FORMULATIONS AND THE ADMINISTRATION THEREOF

French Title of Invention:

FORMULATIONS A BASE DE DILTIAZEM CHRONOTHERAPEUTIQUES ET LEUR ADMINISTRATION

German Title of Invention:

CHRONOTHERAPEUTISCHE DILTIAZEM FORMULIERUNGEN UND DEREN VERABREICHUNG

SPC Number:

Dates

Filing date:

23/05/2000

Grant date:

06/05/2009

EP Publication Date:

06/05/2009

PCT Publication Date:

14/06/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/09/2002

EP B1 Publication Date:

06/05/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/05/2009

Expiration date:

23/05/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/07/2009

 

 

Name:

Biovail Laboratories International SRL

Address:

Welches Christ Church, West Indies 17154, Barbados (BB)

Inventor

1

Name:

ALBERT Kenneth, Stephen

Address:

United States (US)

2

Name:

MAES Paul, Jose

Address:

Canada (CA)

Priority

1

Priority Number:

2292247

Priority Date:

10/12/1999

Priority Country:

Canada (CA)

2

Priority Number:

465338

Priority Date:

17/12/1999

Priority Country:

United States (US)

3

Priority Number:

2307547

Priority Date:

04/05/2000

Priority Country:

Canada (CA)

4

Priority Number:

567451

Priority Date:

08/05/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/50;

Filing date	Document type	Number of pages